CH569009A5 - - Google Patents

Info

Publication number
CH569009A5
CH569009A5 CH1547072A CH1547072A CH569009A5 CH 569009 A5 CH569009 A5 CH 569009A5 CH 1547072 A CH1547072 A CH 1547072A CH 1547072 A CH1547072 A CH 1547072A CH 569009 A5 CH569009 A5 CH 569009A5
Authority
CH
Switzerland
Application number
CH1547072A
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CH569009A5 publication Critical patent/CH569009A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
CH1547072A 1971-12-01 1972-10-23 CH569009A5 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20386971A 1971-12-01 1971-12-01
US00404954A US3850962A (en) 1971-12-01 1973-10-10 2,4-diamino-5-(3-alkoxy-4,5-methylene-dioxybenzyl)pyrimidine
US404953A US3867527A (en) 1971-12-01 1973-10-10 2,4-Diamino-5-(3-alkoxy-4,5-methylenedioxybenzyl)pyrimidine
US05/531,135 US3962435A (en) 1971-12-01 1974-12-09 Combination of oxytetracycline and 2,4-diamino-5-(3-alkoxy-4,5-methylenedioxybenzyl)pyrimidine

Publications (1)

Publication Number Publication Date
CH569009A5 true CH569009A5 (fr) 1975-11-14

Family

ID=27498515

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1547072A CH569009A5 (fr) 1971-12-01 1972-10-23

Country Status (12)

Country Link
US (3) US3850962A (fr)
JP (1) JPS5523830B2 (fr)
AT (1) AT321310B (fr)
AU (1) AU467566B2 (fr)
BE (1) BE792096A (fr)
CA (1) CA994345A (fr)
CH (1) CH569009A5 (fr)
DE (1) DE2252807A1 (fr)
FR (1) FR2162177B1 (fr)
GB (2) GB1388180A (fr)
NL (1) NL176563C (fr)
SE (3) SE397349B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA738760B (en) * 1972-12-21 1974-08-28 Hoffmann La Roche Process for the manufacture of benzyl pyrimidines
US3978086A (en) * 1973-04-13 1976-08-31 Sandoz, Inc. 2-Amino-4,5-methylenedioxyphenyl nitriles
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
US4075209A (en) * 1977-02-07 1978-02-21 Hoffmann-La Roche, Inc. Process for preparing substituted 2,4-diaminopyrimidines and isoxazole intermediate
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use
AT384023B (de) * 1980-11-11 1987-09-25 Wellcome Found Verfahren zur herstellung von neuen 2,4-diamino-5-(subst.)pyrimidinen und deren salzen, n-oxiden und n-acylderivaten
EP3741842A4 (fr) 2018-09-27 2021-04-21 TERUMO Kabushiki Kaisha Méthode de cryoconservation des cellules

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2628236A (en) * 1953-02-10 S-benzyl
DE1303727B (de) * 1959-09-03 1976-02-05 Ausscheidung aus: 14 45 176 The Wellcome Foundation Ltd., London Alpha-Arylidensubstituierte Propioni-Irile
NL122146C (fr) * 1960-09-02
FR1453056A (fr) * 1964-11-12 1966-04-15 Hoffmann La Roche Procédé pour la préparation de dérivés de pyrimidine
US3485840A (en) * 1964-11-12 1969-12-23 Hoffmann La Roche 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes
DE1620729A1 (de) * 1965-07-08 1970-08-20 Wellcome Found Verfahren zur Herstellung von substituierten Benzylpyrimidinen
DK120706B (da) * 1969-01-27 1971-07-05 Egyt Gyogyszervegyeszeti Gyar Fremgangsmåde til fremstilling af 2,4-diamino-5-(3',4',5'-trimethoxybenzyl)-pyrimidin.
CH513181A (de) * 1969-06-12 1971-09-30 Hoffmann La Roche Verfahren zur Herstellung von N-Oxyden von Benzylpyrimidinen
US3787409A (en) * 1970-09-14 1974-01-22 Hoffmann La Roche 2,4-diamino-5-(3-alkoxy-4,5-methylenedioxybenzyl)pyrimidine
RO67383A (fr) * 1970-10-22 1981-07-30 The Wellcome Foundation Ltd,Gb Procede pour la preparation des 2,4-diamino-5-benzylpyrimidines
GB1375162A (fr) * 1970-10-22 1974-11-27
DE2165363A1 (de) * 1970-12-29 1972-07-27 Nisshin Flour Milling Co. Ltd., Tokio Verfahren zur Herstellung von Pyrimidinderivaten

Also Published As

Publication number Publication date
NL176563C (nl) 1985-05-01
NL7215587A (fr) 1973-06-05
US3850962A (en) 1974-11-26
GB1388178A (en) 1975-03-26
AU467566B2 (en) 1975-12-04
FR2162177A1 (fr) 1973-07-13
AU4846272A (en) 1974-05-02
SE397349B (sv) 1977-10-31
FR2162177B1 (fr) 1975-08-08
SE7513517L (sv) 1975-12-01
JPS5523830B2 (fr) 1980-06-25
US3867527A (en) 1975-02-18
JPS4862769A (fr) 1973-09-01
CA994345A (en) 1976-08-03
SE7507943L (sv) 1975-07-10
AT321310B (de) 1975-03-25
NL176563B (nl) 1984-12-03
US3962435A (en) 1976-06-08
GB1388180A (en) 1975-03-26
BE792096A (fr) 1973-05-30
DE2252807A1 (de) 1973-06-07

Similar Documents

Publication Publication Date Title
ATA136472A (fr)
AR196074A1 (fr)
FR2162177B1 (fr)
AU2742671A (fr)
AU2894671A (fr)
AU2941471A (fr)
AU2952271A (fr)
AU3005371A (fr)
AU2938071A (fr)
AU3025871A (fr)
AU2473671A (fr)
AU2755871A (fr)
AU2836771A (fr)
AU2837671A (fr)
AU2854371A (fr)
AR202997Q (fr)
AU1109576A (fr)
AU2880771A (fr)
AU2885171A (fr)
AR192311Q (fr)
AU2927871A (fr)
AU2875571A (fr)
AU2930871A (fr)
AR199640Q (fr)
AU2940971A (fr)

Legal Events

Date Code Title Description
PL Patent ceased